CSF3 and Decreased total neutrophil count: There were 62 patients, including 41 patients in the R-CHOP group (65.1%) and 20 patients in the R-COP group (48.8%), who suffered from grades 3 or 4 leukopenia or neutropenia and received G-CSF administration during first-line chemotherapy treatment.